1st Quarter - Report — AMERICAN THORACIC SOCIETY for AMERICAN THORACIC SOCIETY (2021)

Firm

AMERICAN THORACIC SOCIETY

Client

AMERICAN THORACIC SOCIETY

Income

—

Expenses

$144,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

research and public health funding

Lobbyist	Covered position, as disclosed
NUALA MOORE	—

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Environmental Protection Agency (EPA); Food & Drug Administration (FDA)

Veterans VET

funding for va medical and prosthetics research program

Lobbyist	Covered position, as disclosed
GARY WARREN EWART	—

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; Environmental Protection Agency (EPA)

Foreign Relations FOR

international tb funding

Lobbyist	Covered position, as disclosed
NUALA MOORE	Senior Legislative Representative

Contacted: Food & Drug Administration (FDA); Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; SENATE

Tobacco TOB

tobacco control

Lobbyist	Covered position, as disclosed
GARY WARREN EWART	Director, ATS Government Relations
NUALA MOORE	Senior Legislative Representative

Contacted: Environmental Protection Agency (EPA); Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Clean Air and Water (quality) CAW

air quality

Lobbyist	Covered position, as disclosed
GARY WARREN EWART	Director, ATS Government Relations

Contacted: Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.